FinancingThink about it. If CIN had even an inkling of mediocre or bad results, the company would surely have done a financing by now. Rather, they are holding off until subsequent to assay issuance because they believe they drilled up positive results. The hitch at this point is entirely on the assaying lab in Ancaster (which was closed over the Christmas to New Year week, btw). The slow up is hampering all kinds of plans the company has in terms of the 3 forthcoming shows (the third after Round UP and Cambridge being a Canadian government sponsored Critical Metals conference). CIN was not able to take advantage of the recent share spurt of just about all other REE companies due to lack of assays.
Indeed the delay surely accounts for the mildly faltering shareprice, though it continues to hold up very well.
In terms of negotiating with Spectrum, at some point Spectrum has no choice but to deal with CIN. Of course, they can sell independent of CIN but for any mine to work for them, they have to deal with CIN as the REE moves entirely in the direction of CIN. But any negotiation can only be done from a position of strength and that means good results from assays (which I strongly believe they have but again when will they come out?).